Limitations in thrombolytic therapy in acute ischemic stroke
dc.contributor.author | Kocak, Sedat | |
dc.contributor.author | Dogan, Emine | |
dc.contributor.author | Kokcam, Melek | |
dc.contributor.author | Girisgin, Abdullah Sadik | |
dc.contributor.author | Bodur, Said | |
dc.date.accessioned | 2024-02-23T14:45:36Z | |
dc.date.available | 2024-02-23T14:45:36Z | |
dc.date.issued | 2012 | |
dc.department | NEÜ | en_US |
dc.description.abstract | Objective: The eligibility for thrombolytic therapy for patients who present to the emergency department with Acute Ischaemic Stroke (AIS) has been researched in this study. Methodology: Patients who had presented to the emergency department of our hospital between March 2008-2009 and diagnosed as AIS clinically and radiologically were included in the study prospectively. Results: One hundred and twelve patients were included in the study. Forty nine (43.8 %) were female and the mean age was 68.7 +/- 12.2 (median 71.5). The mean time from the onset of symptom to hospital admission was 12.2 +/- 12.9 hours (median 6 hours). Two (1.8%) patients did not have any contraindication for thrombolytic therapy. Arrival time at the hospital of three hours and higher was the single contraindication in 40 (35.7%) patients. The most common four contraindications were delayed admission, multilobar infarct or hypodensity of more than 1/3 of the hemisphere, hypertension and mild neurological symptoms respectively. Conclusions: Our data suggest that the primary barrier to the delivery of thrombolytic therapy for AIS is delayed arrival of the patient to a hospital, and up to 1/3 of our patients, the percentage arriving within 4 hours of the onset of stroke symptoms, might be eligible for attempted re-perfusion. | en_US |
dc.identifier.endpage | 590 | en_US |
dc.identifier.issn | 1682-024X | |
dc.identifier.issue | 4 | en_US |
dc.identifier.scopus | 2-s2.0-84865164930 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 586 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/17525 | |
dc.identifier.volume | 28 | en_US |
dc.identifier.wos | WOS:000308383400004 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Professional Medical Publications | en_US |
dc.relation.ispartof | Pakistan Journal Of Medical Sciences | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Stroke | en_US |
dc.subject | Acute | en_US |
dc.subject | Thrombolytic Therapy | en_US |
dc.title | Limitations in thrombolytic therapy in acute ischemic stroke | en_US |
dc.type | Article | en_US |